BrigidSweeneyBolandMD
Gastroenterology • La Jolla, CAAdvanced Endoscopic Interventional, Inflammatory Bowel Disease
Associate Professor
Dr. Boland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9350 Campus Point Dr
La Jolla, CA 92037Phone+1 858-657-7423Fax+1 858-657-7259
Education & Training
UC San Diego Medical Center - HillcrestPost-Doctoral Fellowship, 2014 - 2015- University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2010 - 2013
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2008 - 2010
University of California San Francisco School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2010 - 2025- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- Long-Term Outcomes of an Infliximab-First Versus Vedolizumab-First Treatment Strategy in Biologic-Naïve Patients With Ulcerative Colitis.Austin Haynesworth, Kuan-Hung Yeh, Han Hee Lee, Melissa Kirkpatrick, Brigid S Boland
Alimentary Pharmacology & Therapeutics. 2024-12-11 - Correction to: Genetic Risk, Dysbiosis, and Treatment Stratification Using Host Genome and Gut Microbiome in Inflammatory Bowel Disease.Ahmed Moustafa, Weizhong Li, Ericka L Anderson, Emily H MWong, Parambir S Dulai
Clinical and Translational Gastroenterology. 2024-12-10 - Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab Therapy.Rochelle Wong, Paris Charilaou, Amy Hemperly, Lihui Qin, Yushan Pan
Crohn's & Colitis 360. 2024-10-01
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel DiseasesWaseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
- Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis ConceptsParambir S Dulai, William J Sandborn, Brigid S Boland, Derek R Patel, Inflammatory Bowel Diseases
- Join now to see all
Press Mentions
Organoids Derived from Gut Stem Cells Reveal Two Distinct Molecular Subtypes of Crohn’s DiseaseSeptember 26th, 2024- Organoids Derived from Gut Stem Cells Reveal Two Distinct Molecular Subtypes of Crohn’s DiseaseSeptember 26th, 2024
- Dogs Can Be Protective, Including Against Crohn’s DiseaseJune 2nd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
